As of May 2024 Corcept Therapeutics has a market cap of $2.89 Billion. This makes Corcept Therapeutics the world's 3588th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.89 B | -13.46% |
2023 | $3.34 B | 53.13% |
2022 | $2.18 B | -4.36% |
2021 | $2.28 B | -24.78% |
2020 | $3.03 B | 119.26% |
2019 | $1.38 B | -9.81% |
2018 | $1.53 B | -25.44% |
2017 | $2.06 B | 155.69% |
2016 | $0.80 B | 47.63% |
2015 | $0.54 B | 79.5% |
2014 | $0.30 B | -5.1% |
2013 | $0.32 B | 124.55% |
2012 | $0.14 B | -50.45% |
2011 | $0.28 B | 3.07% |
2010 | $0.27 B | 60.92% |
2009 | $0.17 B | 242.17% |
2008 | $50.75 M | -58.46% |
2007 | $0.12 B | 286.1% |
2006 | $31.65 M | -61.7% |
2005 | $82.64 M | -41.6% |
2004 | $0.14 B |
On May 14th, 2024 the market cap of Corcept Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $367.42 B | 12,581.13% | ๐บ๐ธ USA |
Novartis NVS | $210.61 B | 7,168.88% | ๐จ๐ญ Switzerland |
Pfizer PFE | $163.65 B | 5,548.32% | ๐บ๐ธ USA |
Eli Lilly LLY | $747.98 B | 25,715.50% | ๐บ๐ธ USA |
Merck MRK | $335.28 B | 11,471.62% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $91.01 B | 3,041.20% | ๐บ๐ธ USA |
MannKind Corp MNKD | $1.21 B | -58.18% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | $0.44 B | -84.62% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $15.42 B | 432.51% | ๐บ๐ธ USA |